Literature DB >> 11060580

Catheter ablation of ventricular tachycardia related to coronary artery disease: the role of noncontact mapping.

A W Chow1, R J Schilling, N S Peters, D W Davies.   

Abstract

There are a number of limitations associated with conventional mapping for ablation of ventricular tachycardia (VT) in ischemic heart disease, such as the high recurrence rates after initially successful ablation. The development of a noncontact mapping system capable of producing high-resolution isopotential maps of the entire left ventricle has enabled rapid identification of diastolic activity that maintains VT for ablation. With this system it is possible to map nonsustained and fast unstable as well as stable VTs. In this article we review the historic background and concepts of noncontact mapping, its clinical application, and the results of ablations for human VT guided by this mapping system.

Entities:  

Mesh:

Year:  2000        PMID: 11060580     DOI: 10.1007/s11886-000-0038-x

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  42 in total

1.  Exploring postinfarction reentrant ventricular tachycardia with entrainment mapping.

Authors:  W G Stevenson; P L Friedman; P T Sager; L A Saxon; D Kocovic; T Harada; I Wiener; H Khan
Journal:  J Am Coll Cardiol       Date:  1997-05       Impact factor: 24.094

2.  Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1989-08-10       Impact factor: 91.245

3.  Mapping and ablation of ventricular tachycardia with the aid of a non-contact mapping system.

Authors:  R J Schilling; N S Peters; D W Davies
Journal:  Heart       Date:  1999-06       Impact factor: 5.994

4.  Feasibility of a noncontact catheter for endocardial mapping of human ventricular tachycardia.

Authors:  R J Schilling; N S Peters; D W Davies
Journal:  Circulation       Date:  1999-05-18       Impact factor: 29.690

5.  A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.

Authors: 
Journal:  N Engl J Med       Date:  1997-11-27       Impact factor: 91.245

6.  A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators.

Authors:  J W Mason
Journal:  N Engl J Med       Date:  1993-08-12       Impact factor: 91.245

7.  Ventricular activation during ventricular endocardial pacing. II. Role of pace-mapping to localize origin of ventricular tachycardia.

Authors:  M E Josephson; H L Waxman; M E Cain; M J Gardner; A E Buxton
Journal:  Am J Cardiol       Date:  1982-07       Impact factor: 2.778

8.  Prognostic significance of sustained monomorphic ventricular tachycardia induced by programmed ventricular stimulation using up to triple extrastimuli in survivors of acute myocardial infarction.

Authors:  Y Iesaka; A Nogami; K Aonuma; J Nitta; Y H Chun; H Fujiwara; M Hiraoka
Journal:  Am J Cardiol       Date:  1990-05-01       Impact factor: 2.778

9.  Identification and ablation of macroreentrant ventricular tachycardia with the CARTO electroanatomical mapping system.

Authors:  W G Stevenson; E Delacretaz; P L Friedman; K E Ellison
Journal:  Pacing Clin Electrophysiol       Date:  1998-07       Impact factor: 1.976

10.  Out-of-hospital cardiac arrest: electrophysiologic observations and selection of long-term antiarrhythmic therapy.

Authors:  J N Ruskin; J P DiMarco; H Garan
Journal:  N Engl J Med       Date:  1980-09-11       Impact factor: 91.245

View more
  2 in total

1.  Catheter Ablation of Ventricular Tachycardia.

Authors:  Sean P. Tierney; David J. Wilber
Journal:  Curr Treat Options Cardiovasc Med       Date:  2003-10

2.  Techniques for automated local activation time annotation and conduction velocity estimation in cardiac mapping.

Authors:  C D Cantwell; C H Roney; F S Ng; J H Siggers; S J Sherwin; N S Peters
Journal:  Comput Biol Med       Date:  2015-04-25       Impact factor: 4.589

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.